ScholarIQanswers from OpenAlex & ORCID
Ron Handels
ResearcherPublications, citations & collaboration network
Ron Handels is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Ron Handels have?
ScholarIQindexed works
Ron Handels has 133 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Ron Handels have?
ScholarIQcitation count
Ron Handels has 3,664 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Ron Handels?
ScholarIQh-index
Ron Handels has an h-index of 27 in OpenAlex.
What is the i10-index of Ron Handels?
ScholarIQi10-index
Ron Handels has an i10-index of 57 in OpenAlex.
What is the ORCID of Ron Handels?
ScholarIQorcid
The ORCID for Ron Handels is on the source record.
What is the OpenAlex record for Ron Handels?
ScholarIQopenalex
The OpenAlex for Ron Handels is on the source record.
What are the most-cited papers on Ron Handels?
ScholarIQmost cited works
Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and <i>APOE</i> genotype
Lisa Vermunt, Sietske A.M. Sikkes, Ardo van den Hout, Ron Handels, Isabelle Bos, Wiesje M. van der Flier, Silke Kern, Pierre‐Jean Ousset, Paul Maruff, Ingmar Skoog, Frans R.J. Verhey, Yvonne Freund‐Levi, Magda Tsolaki, Åsa K. Wallin, Marcel G. M. Olde Rikkert, Hilkka Soininen, L. Spiru, Henrik Zetterberg, Kaj Blennow, Philip Scheltens, Graciela Muñiz‐Terrera, Pieter Jelle Visser, for the Alzheimer Disease Neuroimaging Initiative, ICTUS/DSA study groups
Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry
Piotr Lewczuk, Peter Riederer, Sid E. O’Bryant, Marcel M. Verbeek, Bruno Dubois, Pieter Jelle Visser, K. A. Jellinger, Sebastiaan Engelborghs, Alfredo Ramı́rez, Lucilla Parnetti, Clifford R. Jack, Charlotte E. Teunissen, Harald Hampel, Alberto Lleó, Frank Jessen, Lidia Glodzik, Mony J. de Leon, Anne M. Fagan, José Luís Molinuevo, Willemijn J. Jansen, Bengt Winblad, Leslie M. Shaw, Ulf Andréasson, Markus Otto, Brit Mollenhauer, Jens Wiltfang, Martin R. Turner, Inga Zerr, Ron Handels, Alexander G. Thompson, Gunilla Johansson, Natalia Ermann, John Q. Trojanowski, Ilker Karaca, Holger Wagner, Patrick Oeckl, Linda van Waalwijk van Doorn, Maria Bjerke, Dimitrios Kapogiannis, H. Bea Kuiperij, Lucia Farotti, Yi Li, Brian A. Gordon, Stéphane Epelbaum, Stephanie J. B. Vos, Catharina J.M. Klijn, William E. Van Nostrand, Carolina Minguillón, Matthias Schmitz, Carla Gallo, Andrea Lopez Mato, Florence Thibaut, Simone Lista, Daniel Alcolea, Henrik Zetterberg, Kaj Blennow, Johannes Kornhuber, on Behalf of the Members of the WFSBP Task Force Working on this Topic: Peter Riederer, Carla Gallo, Dimitrios Kapogiannis, Andrea Lopez Mato, Florence Thibaut
Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum
Willemijn J. Jansen, Olin Janssen, Betty M. Tijms, Stephanie J. B. Vos, Rik Ossenkoppele, Pieter Jelle Visser, Amyloid Biomarker Study Group, Dag Aarsland, Daniel Alcolea, Daniele Altomare, Christine A. F. Von Arnim, Simone Baiardi, Inês Baldeiras, Henryk Barthel, Randall J. Bateman, Bart van Berckel, Alexa Pichet Binette, Kaj Blennow, Merçé Boada, Henning Boecker, Michel Bottlaender, Anouk den Braber, David J. Brooks, Mark A. van Buchem, Vincent Camus, Jose Manuel Carill, Jiří Cerman, Kewei Chen, Gaël Chételat, Elena Chipi, Ann D. Cohen, Alisha Daniels, Marion Delarue, Mira Didic, Alexander Drzezga, Bruno Dubois, Marie Eckerström, Laura L. Ekblad, Sebastiaan Engelborghs, Stéphane Epelbaum, Anne M. Fagan, Yong Fan, Tormod Fladby, Adam Fleisher, Wiesje M. van der Flier, Stefan Förster, Juan Fortea, Kristian Steen Frederiksen, Yvonne Freund‐Levi, Lars Frings, Giovanni B. Frisoni, Lutz Fröhlich, Tomasz Gabryelewicz, Hermann‐Josef Gertz, Kiran Dip Gill, Olymbia Gkatzima, Estrella Gómez‐Tortosa, Timo Grimmer, Eric Guedj, Christian Habeck, Harald Hampel, Ron Handels, Oskar Hansson, Lucrezia Hausner, Sabine Hellwig, Michael T. Heneka, Sanna‐Kaisa Herukka, Helmut Hildebrandt, John R. Hodges, Jakub Hort, Chin‐Chang Huang, Ane Iriondo, Yoshiaki Itoh, Adrian Ivanoiu, William J. Jagust, Frank Jessen, Peter Johannsen, Keith A. Johnson, Ramesh Kandimalla, Elisabeth Kapaki, Silke Kern, Lena Kilander, Aleksandra Klimkowicz‐Mrowiec, William E. Klunk, Norman Koglin, Johannes Kornhuber, Milica G. Kramberger, Hung‐Chou Kuo, Koen Van Laere, Susan Landau, Brigitte Landeau, Dong Young Lee, Mony J. de Leon, Cristian E. Leyton, Kun‐Ju Lin, Alberto Lleó, Malin Löwenmark, Karine Madsen, Wolfgang Maier, Jan Marcusson
Impact of molecular imaging on the diagnostic process in a memory clinic
Rik Ossenkoppele, Niels D. Prins, Yolande A.L. Pijnenburg, Afina W. Lemstra, Wiesje M. van der Flier, Sofie Adriaanse, Albert D. Windhorst, Ron Handels, Claire Wolfs, Pauline Aalten, Frans R.J. Verhey, Marcel M. Verbeek, Mark A. van Buchem, Otto S. Hoekstra, Adriaan A. Lammertsma, Philip Scheltens, Bart N.M. van Berckel
Biomarkers as Predictors for Conversion from Mild Cognitive Impairment to Alzheimer-Type Dementia: Implications for Trial Design
Ineke A. van Rossum, Stephanie J. B. Vos, Ron Handels, Pieter Jelle Visser